New video aims to ease tough hormone decisions for BRCA patients

NCT ID NCT06972719

Recruiting now Knowledge-focused Sponsor: Duke University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 05, 2026 · Updated 3 times

Summary

This pilot study tests whether an educational video can help women with BRCA1 or BRCA2 mutations make more informed decisions about hormone replacement therapy after having their ovaries and fallopian tubes removed to lower cancer risk. Fifty premenopausal women scheduled for this preventive surgery will either receive standard counseling or standard counseling plus the video. Researchers will measure how conflicted patients feel about their decision and how satisfied they are with the counseling.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this educational video could help doctors better support BRCA patients in making informed decisions about hormone therapy after preventive surgery.
What could go wrong: This is a small pilot study (50 people) testing an educational tool, not a treatment. It may not show clear benefits or be generalizable to other hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRCA1 MUTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRCA1 MUTATION BRCA2 MUTATION

Contacts and locations

Locations

Duke University Health System
RECRUITING

Durham, North Carolina, 27710, United States
UNC Chapel Hill Health System
RECRUITING

Chapel Hill, North Carolina, 27514, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.